Device Trial Radar · NCT01532180
Safety and Efficacy of a Hypoglossal Nerve Implant for the Treatment of Obstructive Sleep Apnea (OSA)
Last checked: Nov 19, 2026Latest source record: Aug 12, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
14
Actual
Start
Nov 2009
Primary completion
Dec 2011
Study completion Dec 2011
Sponsor
- Lead sponsor
- ImThera Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Feb 14, 2012
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 25 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the study is to determine the safety and preliminary efficacy in patients utilizing the aura6000 System for the treatment of Obstructive Sleep Apnea (OSA).
Conditions
- Sleep Apnea Syndromes
- Sleep Apnea, Obstructive
- Respiration Disorders
- Signs and Symptoms, Respiratory
- Syndrome, Obstructive Sleep Apnea
Interventions
aura6000 SystemDevice
The aura6000 device is an implanted hypoglossal nerve stimulator designed to maintain wakeful muscle tone of the tongue during sleep. It is implanted through a short surgical procedure. The implant is programmed to provide the optimal stimulation parameters for the patient. The therapy is controlled by a hand-held remote control allowing the patient to start, stop, and pause the therapy during times of sleep.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean change in AHI measured through in-lab polysomnography (PSG) compared to baseline.Time frame: 3 and 12 months post-implant
- Adverse events and Serious Adverse events peri and post-operativelyTime frame: 3 and 12 months post-operative
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Clinique Univ. Saint-Luc
Brussels, Belgium
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.